Biomimx SRL

Biomimx SRL is an SME in Milano, Italy that has taken part in 10 EU-funded projects since 2019, receiving €2.6M in EU funding and leading 2 as coordinator.

EU funding received€2.6M
EU projects10
As coordinator2
Running now7
First EU project2019
Latest project2027
CountryItaly
EU registration (PIC)911866640
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Biomimx SRL's own share of each project, not the project's full budget.

  • Horizon Europe€2.3M · 8 projects
  • Horizon 2020€312k · 2 projects

Projects

10 EU-funded projects, newest first. Biomimx SRL led 2 of them as coordinator. Each links to the official record.

  • GlycoAxisPartner

    Training the next generation of scientists on cell surface Glycans from Gram-negative gut microbiota as molecular keys to decOde the gut-immune-brain Axis

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €282ktheir share
  • BATTITOPartner

    uBeAt-powered closed-loop sTandardisaTion of beatIng heart-on-chip for reliable cardioTOxicity screening

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €75ktheir share
  • AI-RITMIAPartner

    AI-assisted peRsonalized heart-on-chIp as advanced diagnostic Tool for clinical significance assessMent of Inherited cArdiomyopathies

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €580ktheir share
  • MATRIxAssociated partner

    Understanding Nanoparticle Transport Mechanisms in the Melanoma Microenvironment via a Tumor-on-a-Chip Approach

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • PHOENIXPartner

    PHOENIX: Precision Human Organs-on-chip for Enhanced Neuro-muscular and Cardiac Studies

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €787ktheir share
  • IMPLANTEUPartner

    Innovative approaches to implantation research in health and disease

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €259ktheir share
  • MIRACLEPartner

    Multilevel inflammatory regulation in cardiometabolic disease

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €259ktheir share
  • uBeatCoordinator

    Mimic human complexity in a Beat to revolutionize the drug development

    Horizon Europe · 2022–2022 · Project on CORDIS ↗

    €75ktheir share
  • uHeartCoordinator

    A beating Heart-on-Chip for pre-clinical early detection of drugs cardiac safety

    Horizon 2020 · 2019–2020 · Project on CORDIS ↗

    €50ktheir share
  • SINERGIAPartner

    advanced technologieS for drug dIscovery and precisioN mEdicine: in vitRo modellinG human physiology and diseAse

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €262ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • carbohydrates
  • cardiovascular diseases
  • drug discovery
  • drug safety
  • embryology
  • gene therapy
  • immunology
  • melanoma
  • microbiology
  • microelectronics
  • nano-materials
  • nanomedicine
  • neurobiology
  • obstetrics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime